acetylcarnitine has been researched along with Abdominal Migraine in 1 studies
Acetylcarnitine: An acetic acid ester of CARNITINE that facilitates movement of ACETYL COA into the matrices of mammalian MITOCHONDRIA during the oxidation of FATTY ACIDS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hagen, K | 1 |
| Brenner, E | 1 |
| Linde, M | 1 |
| Gravdahl, GB | 1 |
| Tronvik, EA | 1 |
| Engstrøm, M | 1 |
| Sonnewald, U | 1 |
| Helde, G | 1 |
| Stovner, LJ | 1 |
| Sand, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Effect of Acetyl-L-carnitine in Migraine - a Randomized, Double-blind Placebo Controlled Study[NCT01695317] | Phase 4 | 72 participants (Actual) | Interventional | 2013-04-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Secondary measures will be: Days with migraine; days with headache; hours with headache; headache intensity (0-3 scale) on days with headache; doses of analgesics; doses of triptans; days with sick leave; number of responders (≥ 50% decrease in migraine days compared with baseline); incidence of side effects recorded openly. (NCT01695317)
Timeframe: Last 4 weeks
| Intervention | Headache hours per 4 weeks (Mean) |
|---|---|
| Acetyl-L-carnitine | 36.4 |
| Sugar Pills | 37.0 |
The number of days per 4 weeks with moderate or severe headache lasting ≥ 4 hours or if treated with the patient's usual headache medication (usually a triptan) as the primary endpoint. (NCT01695317)
Timeframe: last 4 weeks
| Intervention | Headache days per 4 weeks (Mean) |
|---|---|
| Acetyl-L-carnitine | 5.1 |
| Sugar Pills | 5.2 |
1 trial available for acetylcarnitine and Abdominal Migraine
| Article | Year |
|---|---|
Acetyl-l-carnitine versus placebo for migraine prophylaxis: A randomized, triple-blind, crossover study.
Topics: Acetylcarnitine; Adolescent; Adult; Aged; Cross-Over Studies; Female; Humans; Male; Middle Aged; Mig | 2015 |